☆ 4.7 Letter

Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury

ANNALS OF ONCOLOGY (2017)

Journal

ANNALS OF ONCOLOGY

Volume 28, Issue 3, Pages 671-672

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/annonc/mdw649

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Pharmacology & Pharmacy

Novel Therapies for the Treatment of Drug-Induced Liver Injury: A Systematic Review

Mirjana Stanic Benic, Lana Nezic, Vesna Vujic-Aleksic, Liliana Mititelu-Tartau

Summary: Many drugs can cause hepatotoxicity, and the treatment of drug-induced liver injury (DILI) is challenging. This study searched various databases to summarize the mechanisms, potential benefits, and adverse reactions of novel therapies for managing DILI. The evidence suggests that MgIG treatment may be effective in normalizing ALT levels, while bicyclol treatment may reduce ALT levels.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Plant Sciences

A novel perspective on the preventive treatment of hydrazine compound-induced liver injury: Isoniazid liver injury as an example

Xinyu Li, Chengxian Li, Chenyi Li, Chengzhao Wu, Yuxuan Bai, Xu Zhao, Zhaofang Bai, Xigang Zhang, Xiaohe Xiao, Ming Niu

Summary: This study utilized network pharmacology combined with in vivo and in vitro experiments to demonstrate the effect of dill in alleviating liver injury induced by isoniazid. Dill can alleviate isoniazid liver injury through multiple components, targets, and pathways, as well as regulate the NAT2 enzyme.

JOURNAL OF ETHNOPHARMACOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy

Morven Cunningham, Marco Iafolla, Yada Kanjanapan, Orlando Cerocchi, Marcus Butler, Lillian L. Siu, Philippe L. Bedard, Kendra Ross, Bettina Hansen, Anna Spreafico, Jordan J. Feld

Summary: This study investigated liver enzyme elevation in patients receiving immune checkpoint inhibitors (ICI) and found that immunotoxicity was one of the causes, with a distinct biochemical signature compared to other causes. A diagnostic approach was proposed to help identify patients at higher likelihood of immunotoxicity without the need for liver biopsy in most cases.

PLOS ONE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice

Geng-Ruei Chang, Wei-Li Lin, Tzu-Chun Lin, Huei-Jyuan Liao, Yu-Wen Lu

Summary: Saikosaponin-d (SSd) extracted from Bupleurum falcatum, a traditional Chinese medicinal plant, has hepatoprotective effects in mice with thioacetamide (TAA)-induced liver injury and high-fat-diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppression of inflammatory responses and acting as an antioxidant.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Pharmacology & Pharmacy

The key role of gut-liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity

Yisheng He, Jiang Ma, Xiaoyu Fan, Liang Ding, Xinxin Ding, Qing-Yu Zhang, Ge Lin

Summary: The study revealed the essential role of hepatic P450s in PA bioactivation and the transport of reactive PA metabolites from liver to intestine via bile. Additionally, mice with chronic colitis exhibited exacerbated hepatic damage induced by PA exposure.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Enhanced therapeutic efficacy of a novel self-micellizing nanoformulation-loading fisetin against acetaminophen-induced liver injury

Hui Yang, Qilong Cao, Zhixin Yuan, Xianggen Wu, Mengshuang Li

Summary: The study evaluated the feasibility of using DG as a nanocarrier for loading FIT to strengthen treatment against liver injury induced by acetaminophen overdose. Results showed successful fabrication of DG-FIT with excellent physicochemical properties and significant in vivo efficacy.

NANOMEDICINE (2021)

Add to Collection

Article Gastroenterology & Hepatology

A novel maladaptive unfolded protein response as a mechanism for small bowel resection-induced liver injury

Allie E. Steinberger, Maria E. Tecos, Hannah M. Phelps, Deborah C. Rubin, Nicholas O. Davidson, Jun Guo, Brad W. Warner

Summary: The study reveals that liver injury and fibrosis after small bowel resection (SBR) are mediated by a maladaptive hepatic unfolded protein response (UPR). The hepatic phenotype and UPR pattern can be reversed by a low-fat diet, TUDCA treatment, and ileocecal resection.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2022)

Add to Collection

Article Toxicology

Serious liver injury induced by Nimesulide: an international collaborative study

Fernando Bessone, Nelia Hernandez, Manuel Mendizabal, Ezequiel Ridruejo, Gisela Gualano, Eduardo Fassio, Mirta Peralta, Hugo Fainboim, Margarita Anders, Hugo Tanno, Federico Tanno, Raymundo Parana, Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Ismael Alvarez-Alvarez, Hao Niu, Camilla Stephens, Luis Colombato, Marco Arrese, M. Virginia Reggiardo, Suzane Kioko Ono, Flair Carrilho, M. Isabel Lucena, Raul J. Andrade

Summary: Nimesulide-induced liver injury predominantly affects women and typically presents with a hepatocellular pattern. It is associated with acute liver failure and death in a high proportion of patients. Shorter duration of therapy does not prevent serious nimesulide hepatotoxicity, making its risk/benefit ratio unfavorable.

ARCHIVES OF TOXICOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis

Lin Lei, Alix Bruneau, Haquima El Mourabit, Justine Guegan, Trine Folseraas, Sara Lemoinne, Tom Hemming Karlsen, Benedicte Hoareau, Romain Morichon, Ester Gonzalez-Sanchez, Claire Goumard, Vlad Ratziu, Pierre Charbord, Jeremie Gautheron, Frank Tacke, Thierry Jaffredo, Axelle Cadoret, Chantal Housset

Summary: This study identified portal mesenchymal progenitors of myofibroblasts in liver fibrosis and revealed their role in myofibroblast formation. Portal mesenchymal progenitors play a crucial role in the formation of fibrotic septa, along with neovessels and HSC-MFs that arise from a preexisting pool.

HEPATOLOGY (2022)

Add to Collection

Article Oncology

Nivolumab Combined With Ipilimumab Treatment Induced Hypophysitis and Immune-Mediated Liver Injury in Advanced Esophageal Squamous Cell Carcinoma: A Case Report

Yi Feng, Chengyang Li, Yuan Ji, Ying Liu, Lu Gan, Yiyi Yu, Tianshu Liu

Summary: Immune checkpoint inhibitors have transformed cancer treatment, but strong immune responses can lead to serious immune-related adverse events. We report a case of an advanced esophageal squamous cell carcinoma patient who developed hypophysitis and immune-mediated liver injury after receiving combination therapy with nivolumab and ipilimumab.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Immunology

Hepatocyte growth factor mediates a novel form of hepatic stem/progenitor cell-induced tolerance in a rat xenogeneic liver rejection model

Quanyu Chen, Yu You, Yujun Zhang, Hongyu Zhang, Lianhua Bai

Summary: In this study, the transplantation of NG2(+) HSPs secreting HGF showed prolonged survival times and improved graft functions in a xenogeneic rat acute liver rejection model. The effects were likely associated with HGF secretion and could target recipient CD8(+) T cells by inducing their apoptosis.Interestingly, injection of cHGF also prolonged the survival times of recipient rats and increased the number of apoptotic xenoreactive CD8(+) T cells.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Chemistry, Analytical

A novel precipitating-fluorochrome-based fluorescent probe for monitoring carbon monoxide during drug-induced liver injury

Gui-Qin Fu, Yu-Sang Xia, Wen-Li Jiang, Wen-Xin Wang, Zhi-Ke Tan, Ke-Yue Guo, Guo-Jiang Mao, Chun-Yan Li

Summary: A novel water-soluble fluorescent probe was prepared and successfully applied for CO detection in vivo and in cells. The probe has long emission wavelength and good diffusion resistant ability, showing high selectivity and sensitivity for CO.

TALANTA (2022)

Add to Collection

Article Pharmacology & Pharmacy

Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury

Cristina Rodriguez-Diaz, Bernard Taminiau, Alberto Garcia-Garcia, Alejandro Cueto, Mercedes Robles-Diaz, Aida Ortega-Alonso, Flores Martin-Reyes, Georges Daube, Judith Sanabria-Cabrera, Miguel Jimenez-Perez, M. Isabel Lucena, Raul J. Andrade, Eduardo Garcia-Fuentes, Miren Garcia-Cortes

Summary: The gut microbiota may play a significant role in the progression of NAFLD and DILI. By analyzing the metagenomic profile of the gut microbiota, specific bacterial profiles and metabolic pathways were identified for each liver disorder, providing further insights into their pathophysiology and development.

PHARMACOLOGICAL RESEARCH (2022)

Add to Collection

Article Gastroenterology & Hepatology

Potential benefit and lack of serious risk from corticosteroids in drug-induced liver injury: An international, multicentre, propensity score-matched analysis

Hao Niu, Jiayi Ma, Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Elvira Bonilla-Toyos, Marwan Ghabril, Ma Isabel Lucena, Ismael Alvarez-Alvarez, Raul J. Andrade

Summary: This study investigated the relationship between corticosteroids and the risk of acute liver failure (ALF) in patients with drug-induced liver injury (DILI), and evaluated if corticosteroid therapy improved outcomes in DILI patients. The results showed that corticosteroid therapy did not worsen the outcome in DILI patients, instead, it was associated with a higher rate of liver enzyme normalization.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Add to Collection

Article Multidisciplinary Sciences

Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events

Hirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita, Yuji Miura, Takanobu Motoshima, Kosuke Imamura, Toshiki Kimura, Tokunori Ikeda, Yukio Fujiwara, Hiromu Yano, Tomomi Kamba, Takuro Sakagami, Hiroyuki Oshiumi

Summary: In aged mice, anti-PD-1 therapy induces multiorgan dysfunctions similar to irAEs, with ectopic accumulation of T and B cells in damaged organs. The pathogenicity of ICB-induced irAEs can be alleviated through modulation of the IL-21-CXCL13-auto-antibody axis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial

Alessandra Guido, Dajana Cuicchi, Paolo Castellucci, Francesco Cellini, Francesca Di Fabio, Fabiola Lorena Rojas Llimpe, Lidia Strigari, Milly Buwenge, Savino Cilla, Francesco Deodato, Gabriella Macchia, Erika Galietta, Rita Golfieri, Andrea Ardizzoni, Rocco Maurizio Zagari, Stefano Fanti, Gilberto Poggioli, Lorenzo Fuccio, Alessio G. Morganti

Summary: This study aimed to evaluate the pathological complete response rate of locally advanced rectal cancer after high-dose neoadjuvant chemoradiation based on FDG-PET/CT. The results showed that dose escalation on the target in the final phase of chemoradiation is well tolerated and can provide a high pathological complete response rate.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Add to Collection

Letter Oncology

Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Simone Rossi, Ilaria Cani, Emanuel Raschi, Francesca Comito, Rita Rinaldi, Andrea Ardizzoni, Maria Guarino, Francesco Gelsomino

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Oncology

Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis

Alessandro Di Federico, Andrea De Giglio, Francesco Gelsomino, Francesca Sperandi, Barbara Melotti, Andrea Ardizzoni

Summary: This study aimed to investigate additional factors to PD-L1 expression for the selection of first-line immunotherapy-based treatment for advanced NSCLC patients. The findings suggest that certain clinicopathological and molecular features, such as squamous histology, male sex, smoking history, PD-L1 expression of 50% or more, and high tumor mutational burden, could help improve survival with immunotherapy alone compared to chemotherapy.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Add to Collection

Article Immunology

Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort

Cecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, Zeno Pasquini, Natascia Caroccia, Francesca Fani, Giacomo Fornaro, Renato Pascale, Matteo Rinaldi, Beatrice Miani, Chiara Gamberini, Maria Cristina Morelli, Mariarosa Tame, Marco Busutti, Giorgia Comai, Luciano Potena, Laura Borgese, Elena Salvaterra, Tiziana Lazzarotto, Luigia Scudeller, Pierluigi Viale, Maddalena Giannella

Summary: The relationship between antibody response (AbR) and breakthrough infection (BI) after SARS-CoV-2 vaccination in 614 solid organ transplant (SOT) recipients was analyzed. Heart transplant recipients had the lowest probability of immunization and the highest probability of breakthrough infection. Non-high-level AbR and shorter time from transplantation were associated with breakthrough infection.

CLINICAL INFECTIOUS DISEASES (2023)

Add to Collection

Article Immunology

Relatlimab and nivolumab in untreated advanced melanoma: insight into RELATIVITY

Emanuel Raschi, Francesca Comito, Francesco Massari, Francesco Gelsomino

Summary: Relatlimab plus nivolumab, a novel immunotherapy combination, has been approved by US and EU regulatory agencies for the treatment of advanced melanoma. The RELATIVITY-047 trial showed that this combination has favorable efficacy and tolerability compared to the current standard of care, ipilimumab-nivolumab combination. However, further real-world use and monitoring are needed to fully understand its tolerability and positioning in therapy.

IMMUNOTHERAPY (2023)

Add to Collection

Review Medicine, General & Internal

Planned Extracorporeal Life Support Employment during Liver Transplantation: The Potential of ECMO and CRRT as Preventive Therapies-Case Reports and Literature Review

Cristiana Laici, Amedeo Bianchini, Noemi Miglionico, Niccolo Bambagiotti, Giovanni Vitale, Guido Fallani, Matteo Ravaioli, Antonio Siniscalchi

Summary: Liver transplantation is the gold standard treatment for end-stage liver disease, and the use of ECMO and CRRT support during the peri-transplantation period has shown positive outcomes in managing life-threatening complications. This retrospective study evaluated three clinical cases of planned ECMO support strategies in liver transplantation and found that all three patients had successful outcomes. The use of ECMO and CRRT support in peri-transplantation allows patients to overcome contraindications and undergo liver transplantation successfully.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Oncology

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With BRAF(V600)-Mutant Metastatic Non-Small-Cell Lung Cancer

Gregory J. Riely, Egbert F. Smit, Myung-Ju Ahn, Enriqueta Felip, Suresh S. Ramalingam, Anne Tsao, Melissa Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Michael Offin, Mariano Provencio, Jeffrey Clarke, Maen Hussain, Gregory A. Otterson, Ibiayi Dagogo-Jack, Jonathan W. Goldman, Daniel Morgensztern, Ann Alcasid, Tiziana Usari, Paul Wissel, Keith Wilner, Nuzhat Pathan, Svitlana Tonkovyd, Bruce E. Johnson

Summary: The combination of encorafenib and binimetinib showed clinical efficacy and acceptable safety in patients with BRAF(V600E)-mutant metastatic NSCLC.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Article Clinical Neurology

Peripheral nervous system adverse events associated with immune checkpoint inhibitors

Simone Rossi, Francesco Gelsomino, Rita Rinaldi, Lorenzo Muccioli, Francesca Comito, Alessandro Di Federico, Andrea De Giglio, Giuseppe Lamberti, Elisa Andrini, Veronica Mollica, Roberto D'Angelo, Flavia Baccari, Corrado Zenesini, Pierandrea Madia, Emanuel Raschi, Pietro Cortelli, Andrea Ardizzoni, Maria Guarino

Summary: In this study, researchers investigated immune-related adverse events (irAEs) involving the peripheral nervous system (PNS-irAEs) in cancer patients treated with immune checkpoint inhibitors (ICIs). They found that the incidence of PNS-irAEs was 2.17%, including neuropathies and myasthenia gravis/myositis. Compared to neuropathies, myasthenia gravis/myositis occurred earlier, had a poorer response to treatment, and had a higher mortality rate.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Review Gastroenterology & Hepatology

Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertension

Laura Turco, Thomas Reiberger, Giovanni Vitale, Vincenzo La Mura

Summary: Portal hypertension is a common complication of cirrhosis and plays a crucial role in hepatic decompensation. Carvedilol, a non-selective beta-blocker, has shown superior efficacy in reducing portal hypertension compared to traditional beta-blockers, making it a preferred treatment option for clinically significant portal hypertension in patients with cirrhosis.

LIVER INTERNATIONAL (2023)

Add to Collection

Article Oncology

Correlations between Molecular Alterations, Histopathological Characteristics, and Poor Prognosis in Esophageal Adenocarcinoma

Arianna Orsini, Luca Mastracci, Isotta Bozzarelli, Anna Ferrari, Federica Isidori, Roberto Fiocca, Marialuisa Lugaresi, Antonietta D'Errico, Deborah Malvi, Erica Cataldi-Stagetti, Paola Spaggiari, Anna Tomezzoli, Luca Albarello, Ari Ristimaki, Luca Bottiglieri, Kausilia K. Krishnadath, Riccardo Rosati, Uberto Fumagalli Romario, Giovanni De Manzoni, Jari Rasanen, Giovanni Martinelli, Sandro Mattioli, Elena Bonora

Summary: Esophageal adenocarcinoma (EAC) is a severe malignancy with increasing incidence, poorly understood pathogenesis, and low survival rates. TP53 gene alterations, especially missense mutations, negatively affect cancer-specific survival in EAC. HNF1alpha gene disruption is associated with other gene alterations and is identified as a new EAC-mutated gene.

CANCERS (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series

Elisa Bernasconi, Matteo Biagi, Stefania Di Agostino, Carmela Cursaro, Cristina Felicani, Enrico Ronconi, Elena Franchi, Arianna Carmen Costanzo, Filippo Gabrielli, Alessia Cavicchioli, Giuseppe Ienopoli, Paolo Marenghi, Alessandra Bartoli, Beatrice Serra, Davide Scalabrini, Pamela Sighinolfi, Pietro Andreone

Summary: This study described a case series of patients who developed acute hepatitis following SARS-CoV-2 vaccination or infection, and speculated a possible genetic susceptibility in the pathogenesis.

BIOMEDICINES (2023)

Add to Collection

Article Health Care Sciences & Services

Transesophageal Echocardiography Guidance to Prevent and Manage Pitfalls from Abdominal Normothermic Regional Perfusion and Optimize Timing during Organ Retrieval from a Donor after Circulatory Death

Amedeo Bianchini, Cristiana Laici, Noemi Miglionico, Maria Giacinta Bianchi, Elena Tarozzi, Enrico Bernardi, Jessica Toni, Erika Cordella, Giovanni Vitale, Antonio Siniscalchi

Summary: An essential method for collecting more abdominal donor organs is controlled donation after circulatory death (cDCD). This study presents a case where transesophageal echocardiography (TEE) was used to effectively procure viable abdominal organs from a cDCD donor in the shortest time frame. TEE use leads to a more efficient and effective abdominal normothermic regional perfusion (A-NRP) procedure with limited complications, allowing observation of circulation in both thoracic and abdominal organs with one fast exam. Although prospective studies are needed, TEE could potentially become a standard practice for all DCD organ retrieval procedures.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Add to Collection

Article Gastroenterology & Hepatology

Secondary Sclerosing Cholangitis After SARS-CoV2 : ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?

Alessandra Bartoli, Carmela Cursaro, Hajrie Seferi, Pietro Andreone

Summary: This review focuses on COVID-19 secondary sclerosing cholangiopathy (SSC) and its pathogenesis, with an emphasis on clinical, imaging, and histological findings. The most likely causes of the disease are direct viral cytopathic action and COVID-19-related coagulopathy. Ketamine may be a cofactor but cannot be definitively linked as the main determinant cause of cholangiopathy. Further study is needed due to the severe prognosis of the disease.

HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2023)

Add to Collection

Article Oncology

Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients

Francesca Benevento, Anna Pecorelli, Horia Stefanescu, Zeno Sparchez, Ranka Vukotic, Irene Pettinari, Crina-Anca Grigoras, Francesco Tovoli, Federico Ravaioli, Bernardo Stefanini, Pietro Andreone, Fabio Piscaglia

Summary: This study investigates whether the natural course and response to anticoagulant treatment of bland portal vein thrombosis (PVT) differ between patients with cirrhosis complicated by hepatocellular carcinoma (HCC) and those without HCC. The results show that the presence of active HCC does not affect the course of non-malignant PVT in cirrhosis and that anticoagulation treatment is safe and effective in both HCC and non-HCC patients.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2023)

Add to Collection

Meeting Abstract Gastroenterology & Hepatology

Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis D: results from an interim analysis of a phase 3 randomized study

Heiner Wedemeyer, Soo Aleman, Maurizia Brunetto, Antje Blank, Pietro Andreone, Pavel Bogomolov, Vladimir Chulanov, Nina Mamonova, Natalia Geyvandova, Morozov Viacheslav, Olga Sagalova, Tatyana Stepanova, Dmitry Manuilov, Renee-Claude Mercier, Qi An, John F. Flaherty, Anu Osinusi, Audrey Lau, Julian Schulze Zur Wiesch, Markus Cornberg, Stefan Zeuzem, Pietro Lampertico

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.